
July 1996 VOLUME 45 SUPPLEMENT 3
These pages are best viewed with Netscape version 3.0 or higher or Internet Explorer version 3.0 or higher. When viewed with other browsers, some characters or attributes may not be rendered correctly.
| A JOURNAL OF THE AMERICAN DIABETES ASSOCIATION® |
Proceedings of
the 15th International Diabetes Federation Satellite
Symposium on "Diabetes and Macrovascular
Complications" HAJIME ORIMO, MD, PhD, HAJIME NAWATA, MD, YUTAKA HARANO, MD, PhD, GEROGE STEINER, MD, GUEST EDITORS Diabetes and
Coronary Heart Disease in American Indians Diabetes and
Cardiovascular Disease in a Prospective population Survey
in Japan Coronary Heart Disease and NIDDM
in Japanese-Americans Risk Factor Analyses for
Macrovascular Complication in Nonobese NIDDM Patients Hyperinsulinemia and
Triglyceride-Rich Lipoproteins Diabetic Dyslipidemia Quantitative and Qualitative
Derangement of Apolipoprotein B-Containing Lipoproteins
as a Risk Factor for Diabetic Macroangiopathy in Nonobese
NIDDM Subjects Atherogenic Modified LDL in
Diabetes Cytokines,
Modified Lipoproteins, and Arteriosclerosis in Diabetes Hyperinsulinemia and
Atherosclerosis Effects of Insulin and IGF-I on
Vascular Smooth Muscle Glucose and Cation Metabolism Mechanism and Clinical
Implication of Insulin Resistance Syndrome Augmented Contractile Function
and Abnormal Ca2+
Handling in the Aorta of Zucker Obese Rats With Insulin
Resistance The role of Insulin Resistance in
Korean Patients With Coronary Atherosclerosis Insulin Suppresses Endothelial
Secretion of C-Type Natriuretic Peptide, A Novel
Endothelium-Derived Relaxing Peptide Recent Progress in Advanced
Glycation and Diabetic Vascular Disease; Role of Advanced
Glycation End Product Receptors The Mechanism of Collagen
Cross-Linking in Diabetes Advanced Glycation End products
and Their Recognition by Macrophage and
Macrophage-Derived Cells Rage Involvement of Glycation and Oxidative Stress
in Diabetic Macroangiopathy Glycation, Oxidative Stress,
and Scavenger Activity Intensive Insulin Therapy in Type II Diabetes Diabetic Macroangiopathy and Atherosclerosis Diabetes and Brain Ischemia Asymptomatic Cerebral Small Infarcts
(Lacunae), Their Risk Factors and Intellectual
Disturbances The Clinical Features and Treatment of
Arteriosclerosis Obliterans With Diabetes Biochemical and Molecular Mechanisms in the
Development of Diabetic Vascular Complications Mechanism on Disorders of Coagulation and
Fibrinolysis in Diabetes Prostacyclin-Stimulating Factor, Novel
Protein, and Diabetic Angiopahty Human Arterial Smooth Muscle Cell
Proliferation in Diabetes Vitamin E Normalizes Diacylglycerol - Protein
Kinase C Activation Induced by Hyperglycemia in Rat
Vacular Tissues Criteria for Metabolic Control and
Intervention in Diabetes Hypertriglyceridemia and Low HDL Cholesterol
in Japanese Patients With NIDDM Infrainguinal Reconstruction in
Diabetes Transgenic Mouse and Gene Therapy |
Copyright © 1996 American Diabetes Association
Last updated:7/15/96
For ADA Related Issues contact CustomerService@diabetes.org
For Technical Issues contact webmaster@diabetes.org